ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms

Hirokazu Kurokawa, Carlos L. Arteaga

Research output: Contribution to journalArticlepeer-review

126 Scopus citations

Fingerprint

Dive into the research topics of 'ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms'. Together they form a unique fingerprint.

Medicine & Life Sciences